Metabolic syndrome as a cardiovascular disease risk factor:: Patients evaluated in primary care

被引:37
作者
Cabre, Joan-Josep [1 ]
Martin, Francisco [1 ]
Costa, Bernardo [2 ]
Pinol, Josep L. [3 ,6 ]
Pinol, Josep L. [3 ,6 ]
Ortega, Yolanda [4 ]
Basora, Josep [6 ]
Baldrich, Marta [1 ]
Sola, Rosa [7 ]
Daniel, Jordi [6 ]
Hernandez, Josep Ma [1 ]
Saumell, Judit [4 ]
Blade, Jordi [6 ]
Sagarra, Ramon [1 ]
Basora, Teresa [6 ]
Montanes, Dolors [1 ]
Frigola, Joan L. [1 ]
Donado-Mazarron, Angel
Garcia-Vidal, Maria Teresa [4 ]
Sanchez-Oro, Isabel [2 ]
de Magrina, Josep M. [4 ]
Urbaneja, Ana [5 ]
Barrio, Francisco [2 ]
Vizcaino, Jesus [1 ]
Sabate, Josep M. [1 ]
Pascual, Irene [1 ]
Revuelta, Vanesa [1 ]
机构
[1] ABS Reus 1, Reus 43202, Spain
[2] ABS Reus 2, Reus 43202, Spain
[3] ABS Deltebre, Deltebre 43580, Spain
[4] ABS Reus 4, Reus 43201, Spain
[5] ABS Reus 3, Reus 43201, Spain
[6] Reus Altebrat Primary Care Serv, Reus, Spain
[7] Univ Rovira & Virgili, Fac Med, Reus 43202, Spain
关键词
D O I
10.1186/1471-2458-8-251
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 +/- 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 +/- 10% and 8.8 +/- 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26-5.37), 2.28 (95%CI: 1.84-4.90) and 2.26 (95%CI: 1.48-3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care.
引用
收藏
页数:12
相关论文
共 41 条
[1]
Risk factors and coronary morbimortality in a Mediterranean industrial cohort over 28 years of follow-up.: The Manresa study. [J].
Abadal, LT ;
Lorenzo, CV ;
Pérez, I ;
Puig, T ;
Vintró, IB .
REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (10) :1146-1154
[2]
The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]
2-S
[5]
Prevalence of metabolic syndrome in the Spanish working population:: MESYAS registry [J].
Alegría, E ;
Cordero, A ;
Laclaustra, M ;
Grima, A ;
León, M ;
Casasnovas, JA ;
Luengo, E ;
del Río, A ;
Ferreira, I .
REVISTA ESPANOLA DE CARDIOLOGIA, 2005, 58 (07) :797-806
[6]
NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older [J].
Alexander, CM ;
Landsman, PB ;
Teutsch, SM ;
Haffner, SM .
DIABETES, 2003, 52 (05) :1210-1214
[7]
PREVENCAT study:: control of cardiovascular risk in primary care [J].
Alvarez-Sala, LA ;
Suárez, C ;
Mantilla, T ;
Franch, J ;
Ruilope, LM ;
Banegas, JR ;
Barrios, V .
MEDICINA CLINICA, 2005, 124 (11) :406-410
[8]
AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[9]
The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study [J].
Athyros, VG ;
Bouloukos, VI ;
Pehlivanidis, AN ;
Papageorgiou, AA ;
Dionysopoulou, SG ;
Symeonidis, AN ;
Petridis, DI ;
Kapousouzi, MI ;
Satsoglou, EA ;
Mikhailidis, DP .
DIABETES OBESITY & METABOLISM, 2005, 7 (04) :397-405
[10]
Balkau B, 2002, DIABETES METAB, V28, P364